IMA910
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC
Translational research and the clinical development…
How and when did your company start, and where are you located? immatics has its roots at the University of Tuebingen's…
2522 Background: IMA910 is a novel multi-peptide cancer vaccine consisting of 10 HLA class I and 3class II tumor-associated…
555 Background: Treatment interruption after 12 weeks of oxaliplatin-based therapy followed by re-introduction upon signs of…
3530 Background: IMA910 is a novel cancer vaccine consisting of 10 class I and 3 class II tumor-associated peptides (TUMAPs…
Steffen Walter*, Sabrina Kuttruff*, Andrea Mayer*, Oliver Schoor*, Joerg Ludwig*, Frank Mayerw, Erika Hitrez, Bernhard Roessler…